White Paper Series | March 2026
This white paper is written for leaders of China’s leading crop protection companies that have already built global export scale, but now face a harder question: how to convert volume leadership into durable global value pools under tighter regulation, China+1 supply chains, and rising expectations on innovation, registration, compliance, and local market ownership?
Executive Summary
Chinese crop protection companies have already proven their global competitiveness in scale, cost, and manufacturing reliability. But the next stage of globalization will require a different management discipline. The question is no longer how to sell more products overseas, but how to convert selected products, registrations, partnerships, and capabilities into durable global assets.
The core lesson from Japan is not that Chinese companies should copy Japanese crop protection companies. They should learn from their discipline: focusing capital behind the few products, markets, partners, and capabilities that can become long-term sources of global value.
In brief, Japanese crop protection leaders did three things differently:
- They did not globalize everything. They concentrated resources behind a limited number of products and capabilities with long-term relevance.
- They did not follow one playbook. Sumitomo, Nichino, and Kumiai each chose different pathways based on different starting assets.
- They sequenced expansion carefully. Capability came before scale and control.
For Chinese leaders, the implication is clear:
- Move from “selling what we have” to “investing behind what can become a global asset.”
- Treat registration, partnerships, M&A, and local market control as capital allocation choices, not globalization checklists.
- Choose the globalization pathway that fits the company’s starting advantage and capability maturity, rather than copying the most visible global players.
Section 1: Japan’s Real Lesson – Multiple Pathways, Not One Playbook
The Japanese experience challenges a common assumption in China's globalization debate that there is a single "best" path to international expansion. The three leading Japanese players: Sumitomo Chemical, Nichino, and Kumiai Chemical represent three different globalization pathways, each built around a different starting advantage of its core strategic asset, and a different approach to overseas expansion. Their divergence is precisely what makes them valuable for China.
1.1 Sumitomo Chemical – The Innovation–Led Global Platform Builder
Sumitomo represents the most integrated globalization pathway. Its starting point was proprietary chemistry, supported by sufficient capital and organizational depth to expand progressively across the value chain. Proprietary molecules provided the initial platform for international growth, followed by direct market participation through JVs and subsidiaries, selective investments in manufacturing and supply networks, capability-building in biologicals and biorationals, and targeted acquisitions to strengthen regional market access. Over time, it moved from exporting products to managing a global operating platform.
Sumitomo possessed the combination of proprietary innovation, capital resources, and organizational capability required to manage increasing levels of complexity. Importantly, the company did not pursue platform ownership from the outset; it earned the right to do so by establishing globally relevant products and building capabilities in stages. The key lesson is sequencing. Platform ownership can create value with proven product relevance, registration strength, and organizational readiness. Do not confuse ambition for global control with readiness to manage global complexity.
1.2 Nichino (Nihon Nohyaku) – The Selective Capability Global Expander
Nichino followed a more selective and capital-disciplined route. Itsstarting point was a domestic base built around licensed products. Over time, it added proprietary innovation and expanded internationally by filling specific capability gaps.
Rather than building a broad global footprint, Nichino usedpartnerships, acquisitions, and targeted investments to strengthen selected capabilities: manufacturing, registration, distribution, go-to-market execution, and digital tools in priority markets. Its pathway was not about owning the full system. It was about adding the right capabilities at the right time.
Nichino recognized that its strength as a trusted licensing partner in Japan would not support global
expansion by itself. Leveraging the capabilities and cash flow built in its domestic business, it selectively invested in proprietary innovation while acquiring or partnering to fill critical capability gaps. The result was a capital-efficient, lower-risk globalization pathway built on targeted
capability building rather than pursuing scale or ownership for its own sake.
1.3 Kumiai Chemical – The Molecule-Led Global Developer
Kumiai presents a molecule-led development path. Its core asset was notglobal distribution scale, but the ability to discover and develop proprietary agrochemical molecules.
As a mid-sized company, Kumiai avoided the capital burden of building afull global sales and marketing platform. Instead, it used global partners to support registration, distribution, and market access, allowing the company to monetize proprietary molecules across international markets while staying focused on its strongest capability: innovation.
Kumiai’s strongest competitive advantage is its proprietary molecule innovation capability. Kumiai chose an efficient pathway to achieve international growth by partnering with global players. This enabled the company to maximize returns on R&D without replicating the investment required for a fully integrated global commercial platform. For companies with differentiated innovation, the
lesson is to focus capital where they create unique value and leverage partnerships where others can execute more effectively.
Section 2: What China Can Learn – and What It Must Not Copy
The Japanese examples are valuable because they reveal a disciplined way of thinking about globalization. Sumitomo, Nichino and Kumiai succeeded through different globalization pathways because they started with different assets, capabilities and strategic ambitions.
Successful globalization is less about expanding overseas, and more about making disciplined choices about what to globalize, what capabilities to build, and when to increase control.
2.1 Theme #1 – Globalize Fewer Things, Better
The first Japanese lesson is focus. They concentrated resources behind a small number of molecules and portfolios with technical differentiation, and long-term commercial potential. Sumitomo expanded internationally through proprietary products before building overseas platforms; Nichino narrowed its focus as it moved from licensed products to proprietary innovation; Kumiai built global momentum around molecules such as STAPLE and NOMINEE. They viewed innovation not simply as products to sell, but as strategic assets to monetize through licensing, partnerships, registrations or direct commercialization.
For Chinese companies, the next generation ofglobal winners will not be those with the largest portfolios, but those with the clearest portfolio logic. Globalization begins by deciding which products deserve long-term investment, andhaving the discipline to stop funding those that do not.
2.2 Theme #2 – Building Strategic Options before Scale
Japanese companies invested in assets and relationships that expanded their future choices before they pursued market share. Registration was treated as a strategic investment in future market access, pricing power and commercialization flexibility rather than a compliance process. Partnerships were not simply sales arrangements, but vehicles for acquiring local knowledge, and trusted market access.
For Chinese companies operating in an environment of intense generic competition and rising registration costs, the lesson is equally relevant. Sustainable globalization is built by accumulating assets and relationships that expand future choices, not simply by maximizing today's overseas sales.
2.3 Theme #3 – Build Capabilities Before Ownership
The third lesson is that successful globalization is ultimately a capability-building exercise. The Japanese pathways were built over decades. Their expansion followed a logicalprogression: partnership before ownership, registration accumulation before market control, and capability before scale. This sequencing allowed companies to build registration capability, local knowledge, and customer trust with reduced risk over time. For Chinese players under pressure to deliver near-term
growth, the greatest risk is not moving too slowly but moving into ownership before the necessary capabilities exist.
2.4 Where the Japanese Analogy Breaks
The Japanese experience provides enduring strategic principles, but not a template for execution. Japan globalized in an era of lower competition, less generic overcapacity, more patient investment horizons and fewer geopolitical constraints. Chinese companies start from a different position: larger manufacturing scale, stronger cost competitiveness, faster innovation cycles, more intense generic competition and significantly lower industry margins. Registration and data barriers are also higher, while shareholders often expect faster returns on investment. China should apply Japanese discipline to Chinese realities, e.g., allocate capital more selectively, build capabilities more deliberately and choose globalization pathways that match their own strategic strengths.
Section 3: The “How” – Choosing the Right Globalization Pathway
The Japanese experience leads to one fundamental conclusion: successful globalization is not determined by a single globalization pathway. Chinese leaders should understand how to choose the right one at the right time. It is ultimately a process of making disciplined choices, sequencing investments and adapting as capabilities evolve.
3.1 The Real Challenge Is Not Choosing an Approach
The industry does not suffer from a shortage of globalization approaches. It suffers from a shortage of pathway discipline. Each approach, e.g., license-out, local registration, partnerships, M&A and direct market control, has a legitimate role, but none is universally superior. Licensing can
accelerate monetization of innovation; registration can create market access; partnerships can provide local capabilities; M&A can accelerate capability building; and market control can improve value capture. Yet the same approach that creates value for one company can destroy value for another if applied at the wrong time. The challenge is knowing which approach fits the company's
assets, capabilities and stage of development.
Each approach succeeds only when the necessary conditions exist. Licensing fails when innovation is monetized before its value is fully understood. Registration fails when capital is allocated without a compelling product-market thesis. Partnerships fail when they become transactional sales channels rather than capability-building platforms. M&A fails when companies acquire scale instead of missing capabilities. Market control fails when ownership expands faster than organizational maturity.
Globalization should be viewed as a sequence rather than a collection of disconnected actions. Different companies will follow different paths, but all face the same leadership challenge: how to convert strategic assets into sustainable global value without wasting capital. The objective is not to
maximize overseas activity, but to apply the right approach, for the right asset, at the right time, under the right conditions.
3.2 Beyond Consulting Framework: The Globalization Pathway Navigator
Choosing the right pathway requires more than experience or intuition,but a disciplined process for matching globalization approaches with the company's strongest assets, biggest constraints and evolving capabilities. To support this decision-making process, Beyond Consulting proposes a dynamic framework.
Step 1: Diagnose Where You Are
Every globalization strategy should start with an honest assessment ofthe company's true source of competitive advantage. Some companies possess proprietary molecules with global potential; others are stronger in manufacturing scale or formulation capability. Equally important is understanding the company's significant constraints, whether it is capital availability or market access. A clear understanding of both advantages and constraints provides the foundation for selecting an appropriate globalization pathway.
Step 2: Choose the Right Approach and Design the Pathway
Once the company's starting position is clear, the next step isselecting the approach and pathway that best matches its current capability maturity. For example, molecule innovators may prioritize licensing or co-development, enabling faster monetization. For larger players with capital and portfolio depth, M&A can accelerate globalization, but only it fills a specific capability gap. The objective is not to identify the most ambitious pathway, but the one most likely to create sustainable value under current conditions.
Step 3: Navigate the Journey
Globalization is not a linear journey. Market attractiveness changes, product economics evolve, partnerships mature and company capabilities develop over time. As a result, the optimal pathway today may not be the optimal pathway three years from now. Leading global players regularly reassess their assets, priorities and constraints, adjusting their approach as conditions change. Globalization should therefore be managed as a continuous governance process rather than a one-time strategic initiative.
Conclusion: Globalization Is a Pathway Choice, Not an Activity List
Chinese CP companies already know the menu of globalization approaches. What separates
future winners will be the ability to convert those approaches into a coherent pathway.
The next decade will not reward companies that do everything.
It will reward companies that choose deliberately:
- which products deserve global investment
- which markets justify registration capital
- where partners should carry the company’s portfolio
- where the company should build control
- when M&A creates capability rather than complexity
- when to stop activities that consume capital without building strategic assets
'Going out' is no longer about doing more overseas. It is about choosing the right globalization pathway, funding it properly, and adjusting it with discipline as the company’s capabilities mature. This is the management discipline that will separate Chinese exporters from Chinese global leaders.